RecruitingPhase IIEN originalMelanomaEarly / localized

Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This phase II trial tests how well sulforaphane works in preventing melanoma in patients with multiple atypical moles (nevi) and a prior history of melanoma. Patients with a history of melanoma and multiple atypical nevi are at a significantly increased risk of developing additional melanomas than those without atypical nevi. Prevention measures usually include sun protection, monthly skin self-examinations and regular skin examinations from a doctor. Sulforaphane is a naturally-occurring substance found in many cruciferous vegetables, including broccoli, that may prevent melanoma from forming.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Co najmniej 3 atypowe znamiona na skórze ocenione w ciągu 30 dni przed rozpoczęciem badania
  • •Historia wcześniejszego czerniaków we wczesnym stadium (in situ, stadium I-II lub III bez przerzutów do węzłów)
  • •Wiek co najmniej 18 lat
  • •Brak obecnego leczenia immunologicznego w ciągu ostatniego roku
  • •Nie może być w ciąży - test na ciążę wymagany w ciągu 14 dni przed badaniem
  • •Osoba w wieku rozrodczym musi stosować skuteczną antykoncepcję przez czas badania i 30 dni po zakończeniu

✗ Disqualifies

  • •Przyjmowanie leków ukierunkowanych lub immunoterapii w ciągu 365 dni przed badaniem
  • •Ciąża lub możliwość zajścia w ciążę bez prawidłowej antykoncepcji
  • •Brak oceny co najmniej 3 atypowych znamion w wymaganym czasie

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
September 15, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

UPMC Hillman Cancer Center

Pittsburgh, United States

Trial contact

Site Public Contact

John M. Kirkwood

PRINCIPAL_INVESTIGATOR

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/16/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.